Seeing the full patient journey

Combining longitudinal claims data with deeper inpatient detail supports stronger real-world evidence for life sciences and medical device research.

MarketScan has long been a trusted foundation for longitudinal claims-based research. This episode talks about how the MarketScan partner ecosystem can add new dimensions to that foundation, especially when researchers need deeper visibility into what happens inside the hospital. Guests from FinThrive explain the advantages they have gained from the partner ecosystem.

With guests:

• Liisa Palmer, PhD. Portfolio Leader, Real World Data Research & Analytics, MarketScan
• Luke Boulanger. Director, Technology Product Management, MarketScan
• Ginny Gleason. Principal Consultant, Finthrive
• Stephen Harrop. Business Development Executive, Finthrive

Listen to the episode below:

Free Report

Real-world data use among small to midsize biopharma, medical device companies

As the evidence from real-world data (RWD) continues to meaningfully affect clinical trials and commercial pathways, organisations are more interested in engaging a variety of new datasets. But the trends surrounding that data uptake are rapidly changing, according to a new survey. Download the free report today for data-driven insights into RWD.

Thank you.

You will receive an email shortly. Please check your inbox to download the Report.

By Merative MarketScan

By downloading this Report, you acknowledge that GlobalData may share your information with Merative MarketScan and that your personal data will be used as described in their Privacy Policy